Article
Refining chimeric antigen receptors via barcoded protein domain combination pooled screening
12 Sept 2023
Abstract excerpt
Chimeric antigen receptor (CAR)-T cells represent a promising frontier in cancer immunotherapy. However, the current process for developing new CAR constructs is time consuming and inefficient. To address this challenge and expedite the evaluation and comparison of full-length CAR designs, we have devised a novel cloning strategy. This strategy involves the sequential assembly of individual CAR domains using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
